Open an account

Labcorp Holdings

LH · NYSE

$323.13+$4.30 (+1.35%)TodayMarket closed ·
Prev close $318.83

About LH

Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. The company is headquartered in Burlington, North Carolina and currently employs 71,000 full-time employees. The firm operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The firm is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.

Employees
71,000
Headquarters
Burlington, North Carolina
Listed
Apr 24, 1991
Sector
Health Care
Industry
Health Care Providers & Services
Website
labcorp.com

LH key statistics

Market cap
25.86B
Price-earnings ratio
26.37
Dividend yield
0.92%
Average volume
710.28K
Volume
591.99K
Open price
$321.10
High today
$324.50
Low today
$317.96
52 Week high
$341.80
52 Week low
$244.52

Labcorp Holdings (LH) at a glance

As of Oct 20, 2026, Labcorp Holdings (LH) shares are priced at $323.13, giving the company a market cap of 25.86B, a price-to-earnings ratio of 26.37 and a dividend yield of 0.92%.

Today the stock has traded between $317.96 and $324.50. The current price is 1.6% above the day's low and 0.4% below its high.

Volume so far is 591.99K shares, in line with the average of 710.28K shares a day.

Over the past year Labcorp Holdings has ranged from $244.52 to $341.80, and now sits 81% of the way up that range.

Labcorp Holdings met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q2 FY26 it reported $4.99 per share against an estimate of $4.92.

The average analyst price target is $350.79, 8.6% above the current price, from 10 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

70%of 10 analyst ratings say Buy
  • Buy70.0%
  • Hold30.0%
  • Sell0.0%
Price target · 20 analystsAvg $350.79
Low
$297.61
Now
$323.13
High
$404.25

LH earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 4 of the last 8 quarters, by 1.0% on average.

  1. Q3 FY24: reported $3.50 per share against an estimate of $3.59
  2. Q4 FY24: reported $3.45 per share against an estimate of $3.49
  3. Q1 FY25: reported $3.84 per share against an estimate of $3.85
  4. Q2 FY25: reported $4.35 per share against an estimate of $4.29
  5. Q3 FY25: reported $4.18 per share against an estimate of $4.26
  6. Q4 FY25: reported $4.07 per share against an estimate of $4.06
  7. Q1 FY26: reported $4.25 per share against an estimate of $4.21
  8. Q2 FY26: reported $4.99 per share against an estimate of $4.92

LH news

  • Vandana Singh

    Myriad Genetics Offloads Struggling Prenatal Unit for $210 Million to Labcorp

  • Vandana Singh

    OPKO Health Sheds Diagnostics Businesses in Major Labcorp Deal

  • Press releasePRNewswire

    Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health

  • Press releasePRNewswire

    Labcorp and Arianna Huffington's Thrive Global Collaborate to Launch Thrive 5 Health Test

  • Press releasePRNewswire

    Labcorp to Announce Third Quarter 2026 Financial Results on October 28, 2026

  • Caroline Ryan

    Deal Dispatch: Bending Spoons Acquires Miro For $1.35B, Kinetik Up For Sale, LIV Golf Bankruptcy

  • Vandana Singh

    Labcorp Bets Big on AI, Specialty Testing to Drive Growth Through 2029

  • Press releasePRNewswire

    Labcorp Highlights Strategic Priorities Driving Durable Growth and Shareholder Value at 2026 Investor Day

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.